Chronic myofascial pain syndrome: It may seem simple, but it's not

杜冬萍

DOI: https://doi.org/10.3760/cma.j.cn101658-20201203-00265

2020-01-01

Abstract:Chronic myofascial pain is a complicated syndrome associated with trigger points in taut band of muscle, which would referred to myofascial structure beyond even visceral. Relieving the pain from trigger points should be considered both the primary hurt and corresponding reaction.

What problem does this paper attempt to address?

Advancing musculoskeletal diagnosis and therapy: a comprehensive review of trigger point theory and muscle pain patterns

Tianjun Zhai,Fengyan Jiang,Yeping Chen,Jie Wang,Wei Feng

DOI: https://doi.org/10.3389/fmed.2024.1433070

IF: 3.9

2024-07-10

Frontiers in Medicine

Abstract:Musculoskeletal disorders, especially chronic muscle pain, have a significant impact on public health, affecting millions worldwide. This review examines recent advancements in the diagnosis and management of myofascial pain, with a focus on the refined application of trigger point theory. This theory now incorporates an intricate model that blends biomechanical and neurophysiological mechanisms, essential for understanding the initiation and persistence of pain, and necessitating targeted therapeutic interventions. Utilizing a methodical approach, this paper categorizes muscle pain into three types: Muscle Belly Pain, Origin-Insertion Pain, and Referred Pain, as delineated in the most recent edition of “Myofascial Pain and Dysfunction—The Trigger Point Manual.” Such classification enhances diagnostic precision and therapeutic effectiveness by establishing a specific treatment protocol for each type of pain. The paper discusses the implications of various treatments, such as dry needling and manual therapy, which are informed by empirically derived trigger point charts. These charts are instrumental in pinpointing the exact locations of pain sources and customizing treatment plans. Moreover, this review critically assesses the evolving nature of trigger point charts and champions a holistic approach to pain management. It underscores the necessity of integrating biomechanics, kinesiology, and compensatory mechanisms to provide a comprehensive understanding that allows practitioners to address not only symptomatic pain but also the root causes of musculoskeletal disorders, thereby enhancing long-term patient care outcomes in clinical environments.

medicine, general & internal
Tender points/fibromyalgia vs. trigger points/myofascial pain syndrome: a need for clarity in terminology and differential diagnosis

M J Schneider

Abstract:Objective: This study reviews the clinical distinctions between fibromyalgia (FM) and myofascial pain syndrome (MPS), which represent two separate and distinct soft-tissue syndromes. The major aim of this article is to clarify the terminology associated with these syndromes and clearly define the parameters of differential diagnosis and treatment. Data sources: Pertinent articles in the chiropractic and medical literature are reviewed with an emphasis on the literature published from 1985-1994. Study selection: Studies were selected that emphasized differential diagnosis of FM and MPS, as well as individual articles on either FM or MPS. Data synthesis: The literature on fibromyalgia and myofascial pain syndromes has grown considerably since 1985. It is now clear that there are several important differences between FM and MPS. The most important criteria for differential diagnosis are the presence of tender points (TePs) and widespread, nonspecific, soft tissue pain in FM, compared with regional and characteristic referred pain patterns with discrete muscular trigger points (TrPs) and taut bands of skeletal muscle in MPS. The etiology of TePs is still unknown and it is uncertain which specific soft tissues are tender in FM patients. Myofascial TrPs are found within a taut band of skeletal muscle and have a characteristic "nodular" texture upon palpation. TrPs are thought to develop after trauma, overuse or prolonged spasm of muscles. Local treatment applied to TePs is ineffective, yet specific treatment of TrPs is often dramatically effective. Conclusion: FM and MPS are two different clinical conditions that require different treatment plans. FM is a systemic disease process, apparently caused by dysfunction of the limbic system and/or neuroendocrine axis. It often requires a multidisciplinary treatment approach including psychotherapy, low dose antidepressant medication and a moderate exercise program. MPS is a condition that arises from the referred pain and muscle dysfunction caused by TrPs, which often respond to manual treatment methods such as ischemic compression and various specific stretching techniques. Both of these conditions are seen routinely in chiropractic offices; therefore, it is important for field practitioners to understand these distinctions.
Current advances in the treatment of myofascial pain syndrome with trigger point injections: A review

Nadia Anwar,Xiong Wei,Yuan Jie,Zhao Hongbo,Hao Jin,Zhaoqiong Zhu

DOI: https://doi.org/10.1097/md.0000000000039885

IF: 1.6

2024-10-09

Medicine

Abstract:The original and most commonly accepted definition of Myofascial pain syndrome (MPS) was developed in 1983 in the trigger point manual by Simons and Travell. MPS is chronic regional pain caused by 1 or more myofascial provocation points (also known as trigger points) (MTrP), which manifest as a highly confined and irritable point of tension in the skeletal muscle or fascia that is palpable and produces localized pressure pain when compressed, and induce pain. [ 1 ] MPS is 1 of the main causes of skeletal muscle pain and dysfunction, and in severe cases, anxiety, depression, and other negative emotions, further affecting the quality of life of patients. Therefore, safely and effectively addressing this problem has been challenging in pain clinics.

medicine, general & internal
The pathophysiological nature of sarcomeres in trigger points in patients with myofascial pain syndrome: A preliminary study

Feihong Jin,Yaqiu Guo,Zi Wang,Ahmed Badughaish,Xin Pan,Li Zhang,Feng Qi

DOI: https://doi.org/10.1002/ejp.1647

2020-09-10

European Journal of Pain

Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Myofascial pain syndrome (MPS) has a high global prevalence and is associated with myofascial trigger points (MTrPs) in taut bands or nodules. Little is known about the aetiology. The current study assessed the pathophysiological characteristics of MTrPs in MPS patients.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Biopsies of the trapezius muscle were collected from the MTrPs of MPS patients (MTrP group; n=29) and from healthy controls (control group; n=24), and their morphologies were analysed via haematoxylin‐eosin (H&E) and Masson staining. A protein microarray was used to detect the receptor tyrosine kinase (RTK) family proteins. mRNA and long non‐coding RNA (lncRNA) sequencing and analysis were conducted, and immunohistochemistry and Western blotting were used to examine the expression of EphB and Rho family proteins.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Abnormally contracted sarcomeres showed enlarged, round fibres without inflammation or fibrosis. An lncRNA‐mRNA network analysis revealed activation of muscle contraction signalling pathways in MTrP regions. Among RTK family proteins, 15 exhibited increased phosphorylation, and two exhibited decreased phosphorylation in the MTrP regions relative to control levels. In particular, EphB1/EphB2 phosphorylation was increased on the muscle cell membranes of abnormal sarcomeres. RhoA and Rac1, but not cell division control protein 42 (Cdc42), were activated in the abnormal sarcomeres.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>EphB1/EphB2 and RhoA/Rac1 might play roles in the aetiology of abnormally contracted sarcomeres in MTrPs without inflammatory cell infiltration and fibrotic adhesion.</p></section>

neurosciences,clinical neurology,anesthesiology
Microstructural Abnormalities Were Found In Brain Gray Matter From Patients With Chronic Myofascial Pain (Vol 10, 122, 2016)

Peng Xie,Bangyong Qin,Ganjun Song,Yi Zhang,Song Cao,Jin Yu,Jianjiang Wu,Jiang Wang,Tijiang Zhang,Xiaoming Zhang,Tian Yu,Hong Zheng

DOI: https://doi.org/10.3389/fnana.2016.00122

2017-01-01

Frontiers in Neuroanatomy

Abstract:Myofascial pain, presented as myofascial trigger points (MTrPs)-related pain, is a common, chronic disease involving skeletal muscle, but its underlying mechanisms have been poorly understood. Previous studies have revealed that chronic pain can induce microstructural abnormalities in the cerebral gray matter. However, it remains unclear whether the brain gray matters of patients with chronic MTrPs-related pain undergo alteration. In this study, we employed the Diffusion Kurtosis Imaging (DKI) technique, which is particularly sensitive to brain microstructural perturbation, to monitor the MTrPs related microstructural alterations in brain gray matter of patients with chronic pain. Our results revealed that, in comparison with the healthy controls, patients with chronic myofascial pain exhibited microstructural abnormalities in the cerebral gray matter and these lesions were mainly distributed in the limbic system and the brain areas involved in the pain matrix. In addition, we showed that microstructural abnormalities in the right anterior cingulate cortex (ACC) and medial prefrontal cortex (mPFC) had a significant negative correlation with the course of disease and pain intensity. The results of this study demonstrated for the first time that there are microstructural abnormalities in the brain gray matter of patients with MTrPs-related chronic pain. Our findings may provide new insights into the future development of appropriate therapeutic strategies to this disease.
The deep fascia and its role in chronic pain and pathological conditions: A review

Flemming Kondrup,Nathaly Gaudreault,Gabriel Venne

DOI: https://doi.org/10.1002/ca.23882

Abstract:The deep fascia is a three-dimensional continuum of connective tissue surrounding the bones, muscles, nerves and blood vessels throughout our body. Its importance in chronically debilitating conditions has recently been brought to light. This work investigates changes in these tissues in pathological settings. A state-of-the-art review was conducted in PubMed and Google Scholar following a two-stage process. A first search was performed to identify main types of deep fasciae. A second search was performed to identify studies considering a deep fascia, common pathologies of this deep fascia and the associated alterations in tissue anatomy. We find that five main deep fasciae pathologies are chronic low back pain, chronic neck pain, Dupuytren's disease, plantar fasciitis and iliotibial band syndrome. The corresponding fasciae are respectively the thoracolumbar fascia, the cervical fascia, the palmar fascia, the plantar fascia and the iliotibial tract. Pathological fascia is characterized by increased tissue stiffness along with alterations in myofibroblast activity and the extra-cellular matrix, both in terms of collagen and Matrix Metalloproteases (MMP) levels. Innervation changes such as increased density and sensitization of nociceptive nerve fibers are observed. Additionally, markers of inflammation such as pro-inflammatory cytokines and immune cells are documented. Pain originating from the deep fascia likely results from a combination of increased nerve density, sensitization and chronic nociceptive stimulation, whether physical or chemical. The pathological fascia is characterized by changes in innervation, immunology and tissue contracture. Further investigation is required to best benefit both research opportunities and patient care.
Treatment and management of myofascial pain syndrome

Ivan Urits,Karina Charipova,Kyle Gress,Amanda L Schaaf,Soham Gupta,Hayley C Kiernan,Paula E Choi,Jai Won Jung,Elyse Cornett,Alan D Kaye,Omar Viswanath

DOI: https://doi.org/10.1016/j.bpa.2020.08.003

Abstract:Myofascial Pain Syndrome (MPS) is a regional pain disorder that affects every age-group and is characterized by the presence of trigger points (TrPs) within muscles or fascia. MPS is typically diagnosed via physical exam, and the general agreement for diagnostic criteria includes the presence of TrPs, pain upon palpation, a referred pain pattern, and a local twitch response. The prevalence of MPS among patients presenting to medical clinics due to pain ranges anywhere from 30 to 93%. This may be due to the lack of clear criteria and guidelines in diagnosing MPS. Despite the prevalence of MPS, its pathophysiology remains incompletely understood. There are many different ways to manage and treat MPS. Some include exercise, TrP injections, medications, and other alternative therapies. More research is needed to form uniformly-accepted diagnostic criteria and treatments.
Pathophysiology of Trigger Points in Myofascial Pain Syndrome

Sarah Money

DOI: https://doi.org/10.1080/15360288.2017.1298688

2017-04-03

Abstract:Questions from patients about pain conditions and analgesic pharmacotherapy and responses from authors are presented to help educate patients and make them more effective self-advocates. Trigger point pathophysiology in myofascial pain syndrome, which involves muscle stiffness, tenderness, and pain that radiates to other areas of the body, is considered. The causes of trigger points and several theories about how they develop are reviewed, and treatment approaches, including stretching, physical therapy, dry needling, and injections, are offered.

English Else
Trigger points and acupuncture points for pain: correlations and implications

Ronald Melzack,Dorothy M Stillwell,Elisabeth J Fox

DOI: https://doi.org/10.1016/0304-3959(77)90032-X

IF: 7.926

Pain

Abstract:Trigger points associated with myofascial and visceral pains often lie within the areas of referred pain but many are located at a distance from them. Furthermore, brief, intense stimulation of trigger points frequently produces prolonged relief of pain. These properties of trigger points--their widespread distribution and the pain relief produced by stimulating them--resemble those of acupuncture points for the relief of pain. The purpose of this study was to determine the correlation between trigger points and acupuncture points for pain on the basis of two criteria: spatial distribution and the associated pain pattern. A remarkably high degree (71%) of correspondence was found. This close correlation suggests that trigger points and acupuncture points for pain, though discovered independently and labeled differently, represent the same phenomenon and can be explained in terms of the same underlying neural mechanisms. The mechanisms that play a role in the genesis of trigger points and possible underlying neural processes are discussed.
Scoping review and interpretation of myofascial pain/fibromyalgia syndrome: An attempt to assemble a medical puzzle

Shiloh Plaut

DOI: https://doi.org/10.1371/journal.pone.0263087

IF: 3.7

2022-02-16

PLoS ONE

Abstract:Background: Myofascial Pain Syndrome (MPS) is a common, overlooked, and underdiagnosed condition and has significant burden. MPS is often dismissed by clinicians while patients remain in pain for years. MPS can evolve into fibromyalgia, however, effective treatments for both are lacking due to absence of a clear mechanism. Many studies focus on central sensitization. Therefore, the purpose of this scoping review is to systematically search cross-disciplinary empirical studies of MPS, focusing on mechanical aspects, and suggest an organic mechanism explaining how it might evolve into fibromyalgia. Hopefully, it will advance our understanding of this disease. Methods: Systematically searched multiple phrases in MEDLINE, EMBASE, COCHRANE, PEDro, and medRxiv, majority with no time limit. Inclusion/exclusion based on title and abstract, then full text inspection. Additional literature added on relevant side topics. Review follows PRISMA-ScR guidelines. PROSPERO yet to adapt registration for scoping reviews. Findings: 799 records included. Fascia can adapt to various states by reversibly changing biomechanical and physical properties. Trigger points, tension, and pain are a hallmark of MPS. Myofibroblasts play a role in sustained myofascial tension. Tension can propagate in fascia, possibly supporting a tensegrity framework. Movement and mechanical interventions treat and prevent MPS, while living sedentarily predisposes to MPS and recurrence. Conclusions: MPS can be seen as a pathological state of imbalance in a natural process; manifesting from the inherent properties of the fascia, triggered by a disrupted biomechanical interplay. MPS might evolve into fibromyalgia through deranged myofibroblasts in connective tissue ("fascial armoring"). Movement is an underemployed requisite in modern lifestyle. Lifestyle is linked to pain and suffering. The mechanism of needling is suggested to be more mechanical than currently thought. A "global percutaneous needle fasciotomy" that respects tensegrity principles may treat MPS/fibromyalgia more effectively. "Functional-somatic syndromes" can be seen as one entity (myofibroblast-generated-tensegrity-tension), sharing a common rheuma-psycho-neurological mechanism.
Re-Examining Myofascial Pain Syndrome: Toward Biomarker Development and Mechanism-Based Diagnostic Criteria

Felipe C. K. Duarte,Daniel W. D. West,Lukas D. Linde,Samah Hassan,Dinesh A. Kumbhare

DOI: https://doi.org/10.1007/s11926-021-01024-8

2021-07-08

Current Rheumatology Reports

Abstract:Purpose of ReviewWe discuss the need for a mechanism-based diagnostic framework with a focus on the development of objective measures (e.g., biomarkers) that can potentially be added to the diagnostic criteria of the syndrome. Potential biomarkers are discussed in relation to current knowledge on the pathophysiology of myofascial pain syndrome (MPS), including alterations in redox status, inflammation, and the myofascial trigger point (MTrP) biochemical milieu, as well as imaging and neurophysiological outcomes. Finally, we discuss the long-term goal of conducting a Delphi survey, to assess the influence of putative MPS biomarkers on clinician opinion, in order to ultimately develop new criteria for the diagnosis of MPS.Recent FindingsMyofascial pain syndrome (MPS) is a prevalent healthcare condition associated with muscle weakness, impaired mood, and reduced quality of life. MPS is characterized by the presence of myofascial trigger points (MTrPs): stiff and discrete nodules located within taut bands of skeletal muscle that are painful upon palpation. However, physical examination of MTrPs often yields inconsistent results, and there is no gold standard by which to diagnose MPS.SummaryThe current MPS diagnostic paradigm has an inherent subjectivity and the absence of correlation with the underlying pathophysiology. Recent advancements in ultrasound imaging, systemic biomarkers, MTrP-specific biomarkers, and the assessment of dysfunction in the somatosensorial system may all contribute to improved diagnostic effectiveness of MPS.

rheumatology
Essence of acupoints and meridians based on the studies of myofascial trigger points

郭少卿,徐基民,马彦韬,张艳茹,蒋佳,黄强民

DOI: https://doi.org/10.13703/j.0255-2930.20200327-k0001

2021-01-01

Abstract:Based on the modern anatomy and physiology, the referred pain of myofascial trigger points of each muscle is integrated; compared with the twelve meridians as well as conception vessel and governor vessel, the similarity of their position and running course is observed. With the current research progress of myofascial trigger points and fasciology, based on the running course of referred pain of trigger points, combined with fascia mechanics, nerve and vascular, the location of acupoints and meridians, as well as the relationship between acupoints and meridians, are discussed.
Myofascial pelvic pain: the forgotten player in chronic pelvic pain

Golnaz Namazi,Navya Chauhan,Stephanie Handler

DOI: https://doi.org/10.1097/GCO.0000000000000966

2024-08-01

Abstract:Purpose of review: In this review article, we discuss myofascial-related chronic pelvic pain, pathophysiology, symptomology, and management options. Recent findings: Despite high prevalence of myofascial pelvic pain, screening is not routinely performed by providers. Treatment modalities include pelvic floor physical therapy, pelvic floor trigger point injections with anesthetics or botulinum toxin A and cryotherapy. Other adjunct modalities, such as muscle relaxants and intravaginal benzodiazepines, are used, but data regarding their effectiveness is sparse. Summary: Myofascial pelvic pain is an important, though overlooked component of chronic pelvic pain. Multimodal, multidisciplinary approach including patient education, pelvic floor physical therapy, and trigger point injections is the mainstay of the management of myofascial pelvic pain.
Anatomical Bases of the Temporal Muscle Trigger Points

Luis Carlos Fernandez Garrido,Giulianna Simonetti,Samir Omar Saleh,Flávio Hojaij,Mauro Andrade,Alfredo Luiz Jacomo,Flavia Emi Akamatsu

DOI: https://doi.org/10.1155/2024/6641346

2024-02-25

BioMed Research International

Abstract:Background and Purpose. Myofascial pain syndrome (MPS) is a chronic or acute form of musculoskeletal pain that affects nearly three-quarters of the world's population. It is characterized by muscle pain and stiffness, with palpable nodules and hyperirritability areas called myofascial trigger points (MTPs). The temporal muscle is frequently involved in MPS, and four MTPs in the temporal muscle have been described in the literature, but no anatomical description of the MTPs has been reported. The present study described the entry points of deep temporal nerves in the temporal muscle belly and related these points to the MTPs described in the literature. Method. Temporal muscles of 14 adult cadavers were studied. The muscle bellies were divided into six areas, three superior (1.2 and 3) and three inferior areas (4, 5, and 6) lower, according to a Cartesian plane to analyze and describe the entry points of the branches of the deep temporal nerves into the muscle. The branching distribution was analyzed using Poisson log-linear tests with Bonferroni post hoc tests for comparison between groups (sextants) ( p<0.05 ). Results. Deep temporal nerve entry points were found in the temporal muscle in all areas. Most of the branches were observed in areas 2 and 5, which coincide with the muscle fibers responsible for mandible elevation and related to the previously described MTPs. Fewer branches were found in areas 1 and 6, where contraction produces mandible retraction. Conclusion. There is an anatomical correlation between the branching pattern of the deep temporal nerve and temporal muscle trigger points. Adequate knowledge of the innervation of the temporal muscle may help elucidate the pathophysiology of myofascial syndromes and provide a rational basis for interventional or conservative approaches and help surgeons avoid iatrogenic lesions to the deep temporal nerve lesion.

biotechnology & applied microbiology,medicine, research & experimental
Myofascial Pain Syndrome: A Nociceptive Condition Comorbid with Neuropathic or Nociplastic Pain

César Fernández-de-Las-Peñas,Jo Nijs,Barbara Cagnie,Robert D Gerwin,Gustavo Plaza-Manzano,Juan A Valera-Calero,Lars Arendt-Nielsen

DOI: https://doi.org/10.3390/life13030694

2023-03-03

Abstract:Myofascial pain syndrome is featured by the presence of myofascial trigger points (TrPs). Whether TrPs are primary or secondary phenomena or if they relate to central or peripheral nervous system disorders is controversial. Referred pain, a cardinal sign of TrPs, is a central phenomenon driven by peripheral input. In 2021, the International Association for the Study of Pain (IASP) proposed a clinical criteria and grading system for classifying patients with pain on nociceptive, neuropathic, or nociplastic phenotypes. Myofascial TrP pain has been traditionally categorized as a nociceptive phenotype; however, increasing evidence supports that this condition could be present in patients with predominantly nociplastic pain, particularly when it is associated with an underlying medical condition. The clinical response of some therapeutic approaches for managing TrPs remains unclear. Accordingly, the ability to classify myofascial TrP pain into one of these phenotypes would likely be critical for producing more successful clinical treatment outcomes by a precision medicine approach. This consensus paper presents evidence supporting the possibility of subgrouping individuals with myofascial TrP pain into nociceptive, nociplastic, or mixed-type phenotype. It is concluded that myofascial pain caused by TrPs is primarily a nociceptive pain condition, is unlikely to be classified as neuropathic or nociplastic, but can be present in patients with predominantly neuropathic or nociplastic pain. In the latter cases, management of the predominant central pain problem should be a major treatment goal, but the peripheral drive from TrPs should not be ignored, since TrP treatment has been shown to reduce sensitization-associated symptomatology in nociplastic pain conditions, e.g., fibromyalgia.
Characteristics of patients with myofascial pain syndrome of the low back

Pao-Feng Tsai,Joseph L. Edison,Chih-Hsuan Wang,Michael W. Gramlich,Kailea Q. Manning,Gopikrishna Deshpande,Adil Bashir,JoEllen Sefton

DOI: https://doi.org/10.1038/s41598-024-61319-5

IF: 4.6

2024-05-26

Scientific Reports

Abstract:The objective of this study is to determine characteristics of patients with myofascial pain syndrome (MPS) of the low back and the degree to which the low back pain in the patients examined can be attributed to MPS. Twenty-five subjects with myofascial trigger point(s) [MTrP(s)] on the low back participated in this cross-sectional study. The location, number, and type of selected MTrPs were identified by palpation and verified by ultrasound. Pain pressure threshold, physical function, and other self-reported outcomes were measured. Significant differences were found in Group 1 (Active), 2 (Latent), 3 (Atypical, no twitching but with spontaneous pain), and 4 (Atypical, no twitching and no spontaneous pain) of participants in the number of MTrPs, current pain, and worst pain in the past 24 h ( p = .001–.01). There were interaction effects between spontaneous pain and twitching response on reports of physical function, current pain, and worst pain ( p = .002–.04). Participants in Group 3 reported lower levels of physical function, and higher levels of current pain and worst pain compared to those in Group 4. Participants in Group 1 and 2 had similar levels of physical function, current pain, and worst pain. The number of MTrPs is most closely associated with the level of pain. Spontaneous pain report seems to be a decisive factor associated with poor physical function; however, twitching response is not.

multidisciplinary sciences
Myofascial Pain Syndromes in the Emergency Department: What Are We Missing?

Carlos J Roldan,Na Hu,Carlos J. Roldan

DOI: https://doi.org/10.1016/j.jemermed.2015.04.027

2015-12-01

Abstract:BACKGROUND: Myofascial pain syndrome (MPS), pain originating in the myofascial tissue, is a widely recognized pathology characterized by the presence of referred pain (often distant from its origin and specific to each muscle) that can resemble other pathologies and by the presence of a trigger point, a localized hyperirritable band able to reproduce the pain and its associated symptoms. Patients with acute or chronic MPS are commonly seen in the emergency department (ED), usually complaining of pain of undetermined origin. Traditionally, the emergency physician (EP) is not trained to diagnose and treat MPS, and many patients with MPS have received less than optimal management of this condition in the ED. Many types of treatments are known to be effective against MPS. Among these, trigger point injection (TPI) is considered a practical and rapid approach that can be carried out in the ED by EPs.OBJECTIVE: This article reviews the current diagnostic methods, treatment options, and procedures for MPS patients seen in the ED to enable EPs to diagnose and successfully treat this condition.DISCUSSION: This article discusses the clinical characteristics, etiology, diagnosis, and treatment of MPS in the ED, including a description of performing TPI.CONCLUSIONS: MPS can mimic other clinical conditions commonly seen in the ED. MPS can be diagnosed on the basis of clinical findings; in many cases, no imaging or laboratory testing is needed. Therefore, MPS diagnosis and treatment can be successfully accomplished in the ED by EPs.
Expert Consensus on the Diagnosis and Treatment of Myofascial Pain Syndrome

Qi-Wang Cao,Bao-Gan Peng,Lin Wang,You-Qing Huang,Dong-Lin Jia,Hao Jiang,Yan Lv,Xian-Guo Liu,Rong-Guo Liu,Ying Li,Tao Song,Wen Shen,Ling-Zhi Yu,Yong-Jun Zheng,Yan-Qing Liu,Dong Huang

DOI: https://doi.org/10.12998/wjcc.v9.i9.2077

2021-01-01

World Journal of Clinical Cases

Abstract:Myofascial pain syndrome (MPS) is characterized by myofascial trigger points and fascial constrictions. At present, domestic and foreign scholars have not reached a consensus on the etiology and pathogenesis of MPS. Due to the lack of specific laboratory indicators and imaging evidence, there is no unified diagnostic criteria for MPS, making it easy to confuse with other diseases. The Chinese Association for the Study of Pain organized domestic experts to formulate this Chinese Pain Specialist Consensus on the diagnosis and treatment of MPS. This article reviews relevant domestic and foreign literature on the definition, epidemiology, pathogenesis, clinical manifestation, diagnostic criteria and treatments of MPS. The consensus is intended to normalize the diagnosis and treatment of MPS and be used by first-line doctors, including pain physicians to manage patients with MPS.
Intrafasciomembranal Fluid Pressure: A Novel Approach to the Etiology of Myalgias

Stig Runar Hopen

DOI: https://doi.org/10.7759/cureus.28475

2022-08-27

Cureus

Abstract:Fascia is a continuous membrane (fasciomembrane) that enables differentiation of fluid pressure on either side. Fascia membrane also enables an internal increased fluid pressure at all muscle levels (fibers, fiber bundles, skeletal muscles, compartments), and the author introduces a new unifying term for these pressures, regardless of the anatomical level - the intrafasciomembranal fluid pressure (IFMFP). Swelling, pain, and loss of tissue function are identified as common cardinal symptoms in trigger point (TrP), chronic exertional compartment syndrome (CECS), overtraining syndrome (OTS), and delayed onset muscle soreness (DOMS). Existing literature and an overall assessment indicate that intramuscular conditions related to fluid flow and pressure play a central role in different conditions, providing a common biomechanical explanation of the etiology and influence, supporting the article's theory that an increased IFMFP plays a key role in these conditions.
Chronic non-inflammatory muscle pain: central and peripheral mediators

Joseph Lesnak,Kathleen A Sluka

DOI: https://doi.org/10.1016/j.cophys.2019.06.006

2019-10-01

Current Opinion in Physiology

Abstract:Conditions with chronic widespread non-inflammatory muscle pain, such as fibromyalgia, have complex etiologies with numerous proposed mechanisms for their pathophysiology of underlying chronic pain. Advancements in neuroimaging have allowed for the study of brain function and connectivity in humans with these conditions, while development of animal models have allowed for the study of both peripheral and central factors that lead to chronic pain. This article reviews the current literature surrounding the pathophysiology of chronic widespread non-inflammatory muscle pain focusing on both peripheral and central nervous system, as well as immune system, contributions to the development and maintenance of pain. A better understanding of the mechanisms underlying these conditions can allow for improvements in patient education, treatment and outcomes.

Chronic myofascial pain syndrome: It may seem simple, but it's not

Advancing musculoskeletal diagnosis and therapy: a comprehensive review of trigger point theory and muscle pain patterns

Tender points/fibromyalgia vs. trigger points/myofascial pain syndrome: a need for clarity in terminology and differential diagnosis

Current advances in the treatment of myofascial pain syndrome with trigger point injections: A review

The pathophysiological nature of sarcomeres in trigger points in patients with myofascial pain syndrome: A preliminary study

Microstructural Abnormalities Were Found In Brain Gray Matter From Patients With Chronic Myofascial Pain (Vol 10, 122, 2016)

The deep fascia and its role in chronic pain and pathological conditions: A review

Treatment and management of myofascial pain syndrome

Pathophysiology of Trigger Points in Myofascial Pain Syndrome

Trigger points and acupuncture points for pain: correlations and implications

Scoping review and interpretation of myofascial pain/fibromyalgia syndrome: An attempt to assemble a medical puzzle

Re-Examining Myofascial Pain Syndrome: Toward Biomarker Development and Mechanism-Based Diagnostic Criteria

Essence of acupoints and meridians based on the studies of myofascial trigger points

Myofascial pelvic pain: the forgotten player in chronic pelvic pain

Anatomical Bases of the Temporal Muscle Trigger Points

Myofascial Pain Syndrome: A Nociceptive Condition Comorbid with Neuropathic or Nociplastic Pain

Characteristics of patients with myofascial pain syndrome of the low back

Myofascial Pain Syndromes in the Emergency Department: What Are We Missing?

Expert Consensus on the Diagnosis and Treatment of Myofascial Pain Syndrome

Intrafasciomembranal Fluid Pressure: A Novel Approach to the Etiology of Myalgias

Chronic non-inflammatory muscle pain: central and peripheral mediators